As competition for physicians’ time intensifies, the traditional sales force model is challenged to deliver the returns it once did by creating and managing an integrated channel management strategy, you can better allocate sales and marketing resources to make the most of your limited budgets.
Learn how to customize a cost-effective communications mix that is continually monitored and updated across multiple channels, including sales reps, so that you can drive prescription growth at any point in your commercial lifecycle – from launch to loss of exclusivity.
Join us for a complimentary webinar and learn about:
- The importance of physician communication channel preference data
- Integrated campaign design using 4 critical elements: data, insights, technology and channels
- Continuous optimization and Execution of the right channel mix strategy
- Integration of a multichannel campaign with your sales force
- Bolstering campaign results at any point in your product’s commercial lifecycle
Peter Dussias, Executive Director, Integrated Channel Management Services, Quintiles
Peter brings 21 years experience in the Pharmaceutical industry serving in a variety of sales, product development, and analytic services roles with top Pharmaceutical companies and professional services firms. In his current role within Quintiles commercial operations, Peter directs integrated channel management services.
Who Should Attend?
Senior level executives from pharma/biotech companies involved in:
- Brand/product management
- Brand communications
- Therapy/disease management (commercial functions)
Quintiles is the only fully integrated bioPharmaceutical services company offering comprehensive solutions worldwide across the product lifecycle. Our network of more than 27,000 professionals in 100 countries has an eye on the future while delivering results today with an unwavering commitment to patients, safety and ethics. Quintiles helps bioPharmaceutical companies develop and commercialize products to improve and lengthen patients’ lives while demonstrating value to stakeholders.
As a pioneer in bioPharmaceutical services, Quintiles has helped develop or commercialize all of the top 50 best-selling drugs during our 30 years of experience. We have supported over 80 product launches in the US, including 25 companies who were launching a product for the first time. The benefits of our partnership model include retention of strategic control, long term value maximization, operational risk management, and corporate and operational flexibility, and hence offers an attractive alternative to traditional co-promotion and out-licensing approaches.
Please visit our website for more information.